A novel ensemble fuzzy classification model in SARS-CoV-2 B-cell epitope identification for development of protein-based vaccine
Loading...
Files
Date
2022
Authors
Journal Title
Journal ISSN
Volume Title
Publisher
Elsevier Ltd
Access Rights
info:eu-repo/semantics/openAccess
Abstract
B-cell epitope prediction research has received growing interest since the development of the first method. B-cell epitope identification with the aid of an accurate prediction method is one of the most important steps in epitope-based vaccine development, immunodiagnostic testing, antibody production, disease diagnosis, and treatment. Nevertheless, using experimental methods in epitope mapping is very time-consuming, costly, and labor-intensive. Therefore, although successful predictions with in silico methods are very important in epitope prediction, there are limited studies in this area. The aim of this study is to propose a new approach for successfully predicting B-cell epitopes for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In this study, the SARS-CoV B-cell epitope prediction performances of different fuzzy learning classification models genetic cooperative competitive learning (GCCL), fuzzy genetics-based machine learning (GBML), Chi's method (CHI), Ishibuchi's method with weight factor (W), structural learning algorithm on vague environment (SLAVE) and the state-of-the-art ensemble fuzzy classification model were compared. The obtained results showed that the proposed ensemble approach has the lowest error in SARS-CoV B-cell epitope estimation compared to the base fuzzy learners (average error rates; ensemble fuzzy=8.33, GCCL=30.42, GBML=23.82, CHI=29.17, W=46.25, and SLAVE=20.42). SARS-CoV and SARS-CoV-2 have high genome similarities. Therefore, the most successful method determined for SARS-CoV B-cell epitope prediction was used in SARS-CoV-2 cell epitope prediction. Finally, the eventual B-cell epitope prediction results obtained for SARS-CoV-2 with the ensemble fuzzy classification model were compared with the epitope sequences predicted by the BepiPred server and immunoinformatics studies in the literature for the same protein sequences according to VaxiJen 2.0 scores. We hope that the developed epitope prediction method will help design effective vaccines and drugs against future outbreaks of the coronavirus family, especially SARS-CoV-2 and its possible mutations. © 2021 Elsevier B.V.
Description
Keywords
B-cell, Epitope, Fuzzy learning, SARS-CoV, SARS-CoV-2, Spike protein, Cells, Cytology, Diagnosis, Diseases, Epitopes, Forecasting, Fuzzy systems, Learning algorithms, Machine learning, Proteins, Vaccines, B cell epitopes predictions, B cells, Cell epitopes, Epitope predictions, Fuzzy learning, Prediction methods, SARS-CoV, Severe acute respiratory syndrome coronavirus, Severe acute respiratory syndrome coronavirus 2, Spike protein, SARS
Journal or Series
Applied Soft Computing
WoS Q Value
Scopus Q Value
Q1
Volume
116
